Emma Walmsley, GSK CEO (Kevin Dietsch/Pool via CNP/Alamy)

GSK dou­bles down on vac­cines, HIV meds as CEO Em­ma Walm­s­ley touts 'land­mark' 2022

The step change that Em­ma Walm­s­ley promised at GSK is here, and the CEO has fi­nan­cial re­sults that sur­passed fore­casts to show for it. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.